Medical network - February 20 February 16, taizhou, jiangsu province who planning commission issued a notice, asking for the jiangsu province taizhou public medical and health institution clinical inspection reagent consumables procurement and distribution management method "in the revision opinion.
According to the notice, taizhou of public medical institutions in the city of clinical laboratory reagents and consumables procurement directory management, procurement management mode classification, distributors qualification certification, unified distribution management, and other measures. Several of these rules is "strict" and "advanced".
Notification requirements, within the scope of taizhou, open reagents and consumable materials that is used by the public medical institutions shall be organized by the city health development planning commission after comprehensive evaluation, public bidding to determine for products, and domestic products are preferable. Special reagent and new test projects outside the directory, reagents used filing management.
In the mode of procurement, to implement centralized procurement and joint procurement, more than a year the actual usage of medical institutions and the purchase price as the base, based on the principle of link quantity and price, combined with the technical standard to produce new GongYingJia in public bidding and distributors. Tertiary hospital allowed to purchase, but also shall not be higher than in the centralized purchasing price.
Notification is also proposed to strictly implement the "two votes", and it is strictly prohibited to the winning distributors will be the winning distribution business subcontract, the subcontract. Implements two votes for IVD reagents and consumables, taizhou walk in front of the rest of the country.
With "two votes first province medical consumables" strict selection of shaanxi province similar material distributors, taizhou shall manage the qualification admittance to the distributors, only satisfy certain conditions, the public bidding for business, can be engaged in clinical laboratory reagent consumables distribution in the city.
Fundamental threshold of distributors, including: must be in sales test reagents, supplies more than 50 million yuan, has more than 500 m in taizhou after a cool library, more than 300 m after cold storage, with cold-chain distribution business more than 3 units, nearly three years without illegal business behavior, etc.
Medical instrument marketing expert wang qiang against blue parker said instrument, the above conditions for distributors is relatively harsh.
The blue parker, a senior adviser, medical equipment industry well-known policy and marketing experts, also think the selection is quite harsh conditions for distributors, most enterprises cannot meet the conditions, or will face the market.
Another consumables executives Xue Xiansheng against blue parker said instrument, the cold storage volume of 300 cubic meters and 50 million sales, high threshold, "the two votes must be strictly implemented, is certainly big logistics platform can meet the requirements. Two votes is to reduce the circulation link, the significance of purifying the circulation environment, boosting enterprise transformation and upgrading, improve industry concentration, realize 3 d linkage reform", he said.
In addition, taizhou health development planning commission also emphasized in the notice, public medical institutions are strictly prohibited to accept any form of inspection equipment, and supplies equipment bundle shall be strictly prohibited. Cooperation of clinical laboratory, partners should be on the list of qualified distributors, authorized to implement cooperation way, the reagent consumables procurement price is the same type unit purchase price shall not be higher than the same region.
Taizhou development planning commission of this paper of the notification, in the face of the city from the aspects has carried on the strict test reagents and consumables procurement specification, if implemented, is the new big market reshuffle. And the reason for such a "strict", and the city had earlier found a large number of clinical laboratory corruption cases.
In August 2014, taizhou people's hospital clinical laboratory ya-bao Chen, director of the alleged bribery case investigation by the procuratorial organs, kicked off the taizhou, is jiangsu province against corruption in the field of medical apparatus and instruments, and clinical laboratory is the top priority.
The anti-corruption storm spread to the vast majority of cities in jiangsu, time lasted from 2014 to 2014, 2016, and now is not over yet. Changzhou there are 2 hospitals in recently two bribery, director of the department are found out. List of relevant anti-corruption efforts and the blue equipment, also has many public parker.
Specific to taizhou, so far, because of the bribery of clinical laboratory personnel, including:
1, taizhou ya-bao Chen, director of the people's hospital clinical laboratory, bribery, more than 130 ten thousand yuan, sentenced to four years and 6 months, 540000 fine;
2, the second people's hospital clinical laboratory taizhou Xu Jun, director of the original;
3, the second people's hospital of taizhou original Lv love bin, deputy director of clinical laboratory;
4, taizhou dong-xing wang, director of the third people's hospital clinical laboratory, sentenced to five years of trial, and confiscation of property 50000 yuan;
5, taizhou Feng Yasong, director of the fourth people's hospital clinical laboratory, personal bribery, bribery, nearly 500000 90000 multivariate, participation units, sentenced to 2 years and 8 months, a fine of 140000 yuan.
6, taizhou fourth people's hospital clinical laboratory, director of the center laboratory Xu Xiaofeng, deputy director of the original unit bribery, bribery, 140000, participate in nearly 500000, sentenced to three years, RMB 210000 fine;
7, taizhou hospital clinical laboratory Wang Yuming, director of the original;
8, taizhou combine traditional Chinese and western medicine hospital clinical laboratory director Ding Xiaodong, sentenced to 10 years, 2 months of trial and confiscation of property 100000 yuan;
9, taixing city people's hospital clinical laboratory director gui-lan;
10, taixing city people's hospital clinical laboratory, deputy director of the original Li Wanfang;
11, xinghua TaiHongMing, director of the people's hospital clinical laboratory;
12, jingjiang city people's hospital clinical laboratory director Zhou Mingxian;
In addition, the fourth people's hospital of taizhou clinical laboratory and taixing city people's hospital clinical laboratory are suspected of unit bribery, taizhou fourth people's hospital clinical laboratory has been sentenced to a fine of 350000 yuan, and confiscate the illegal income department, the state Treasury.
, so to speak, in taizhou, the procuratorial organs of the medical anti-corruption storm the city each big hospital inspection department head almost completely annihilated. Such efforts, even disturb the highest inspection, once be separately. Taizhou procuratorate also specially joint taizhou health development planning commission held in the city's medical test area position crime case analysis will, procuratorate ask who plan system effectively enhance the sense of responsibility and urgency, to further strengthen and improve the health meter system prevent position crime. Taizhou health development planning commission's latest "restrictive", is can be seen as strengthening clinical laboratory corruption prevention, make up for the loopholes reagents material bidding procurement forceful measures.
It is important to note that since taizhou large-scale down, director of the clinical laboratory in changzhou city of jiangsu province, nanjing, lianyungang, wuxi, zhenjiang, yangzhou also have to examine a large number of clinical laboratory corruption cases, by the city became a province anti-corruption anti-corruption campaign. This time, taizhou new prevention clinical laboratory measures of corruption, is likely to be in after also be reference to other places in jiangsu province.
Attachment: taizhou public medical and health institution clinical laboratory reagent consumables procurement and distribution management regulations (draft)
One, the general
Article 1 with a view to further strengthen public medical and health institution clinical examination reagent consumables procurement and distribution management, improve the pharmaceutical sales management mechanism, active prevention and governance commercial bribery, according to the state council about print and distribute "much starker choices-and graver consequences-in" deepening the reform of medical health system planning notice spirit, combined with the actual, these measures are formulated.
Referred to in article 2 these measures within the scope of the jurisdiction of public medical and health institution refers to the city's comprehensive public one, two, three, hospital and specialized subject hospital, maternity care, skin have, by the centers for disease control and prevention, blood stations and other medical and health institutions.
Clinical laboratory reagent of outpatient emergency care and ward inspection for all biological and chemical reagent, used for the experiment and research test reagents is not one of them.
Consumables, it refers to applied directly to the one-time consumables associated clinical test.
Article 3 taizhou health and family planning commission is responsible for the city's public medical and health institution clinical inspection reagent consumables procurement and distribution of guidance, organization, supervision and so on related work, within the scope of the department functions and powers, bear the city public medical and health institution clinical inspection reagent consumables procurement and distribution management.
Cities (districts) and the family planning administrative department of health is responsible for the related medical and health institutions within their respective areas of clinical inspection reagent consumables procurement and distribution of organization, management and supervision and so on related work.
Article 4 the public medical institutions clinical test reagent consumables procurement and distribution, practice the distributors qualification admittance, test reagents and consumables procurement directory management, procurement methods (packaging procurement, joint procurement, centralized purchasing, price negotiation) principle of classification management, unified distribution, etc.
City and each city (area) and the family planning administrative department of public health should be strengthened and the disciplinary inspection, prosecution, drug safety and departments such as finance, audit, perfecting related management system together, should build a pharmaceutical sales field, comprehensive governance mechanisms.
Second, the distributors qualification admittance management
Article 5 in taizhou supplies distribution within the scope of clinical laboratory reagent distributors, should possess the following basic conditions:
(a) have the ability to bear civil liability independently, have good commercial reputation and sound financial and accounting system; Has to fulfill the corresponding equipment distribution business, capital, personnel and professional and technical ability; Has a proven track record of consistently lawfully pay taxes and social security funds.
(2) for nearly three years business activities in the no criminal record.
(3) have YaoXie commodity business licenses.
(4) more than 3 cold-chain distribution chariots, can provide real-time cold-chain monitoring data, set up a cool library in taizhou range over 500 m3, 300 m3 above refrigerated warehouse.
(五) years sales test reagents, consumables, 50 million yuan of above.
(6) other conditions conforming to the provisions of laws and regulations.
Article 6 distributors entry qualifications in a unified manner by taizhou health and family planning commission. After public bidding for distributors, the party is entitled to conduct clinical within the scope of taizhou inspection reagent consumables distribution business.
Distributors entry qualifications, valid for 2 years. Should reorganize after the expiration of the qualification.
Entry qualification institution can according to need, supplemented distributors in public bidding way.
Article 7 the clinical laboratory reagent consumables distributors shall practise a system of annual inspection. Not qualified distributors in the annual inspection, repel and declared by the admittance qualification institution; Of a major violation of distributors, access qualification institution in the fact that even after declared to repel.
Three, reagents, consumables procurement directory management
Article 8 the clinical laboratory reagents and consumables catalogue management system.
By taizhou open reagents and consumables, health and family planning commission in accordance with the priority principle of domestic products, according to the price, market share, enterprise strength, such as after-sales service ability index comprehensive evaluation organization, after public bidding procedures to determine shortlisted for the product.
Directory outside the special reagent and new reagents needed for inspection project, a filing management system.
Article 9 the reagent consumables procurement directory is valid for 2 years. Reagent consumables procurement directory once released, the city's public medical and health institution should be carried out within the scope of the catalogue purchasing.
Fourth, centralized purchasing management
Article 10 the public medical institutions in the city of clinical laboratory reagents and consumables centralized purchasing, by taizhou health and family planning commission or the various cities (districts) in a unified manner by the family planning administrative department of public health.
Cities (districts) according to the centralized purchasing or joint procurement. Centralized purchasing in accordance with the tender point one year each city (area) the public medical institutions of the actual use test reagents and consumable materials used and the purchasing price of base, based on the principle of link quantity and price, combined with the technical standard in public bidding produce clinical inspection reagent consumables GongYingJia and distributors. Joint procurement can be made up of two listed (area) for centralized procurement according to the above method.
Bidding period is two years commonly, special circumstances by taizhou health and family planning commission approved can extend or shorten the bidding period.
Article 11 according to the packing of the third class hospitals purchasing or joint purchase manner, purchase bidding plan to submit the consent from taizhou health and family planning commission review, by the hospital or medical couplet body the second paragraph of article 10 of the present measures shall be stipulated procurement on its own.
Tertiary hospitals mechanism of price negotiation results to be Shared. Tertiary hospital inspection reagents and consumable purchase price shall not be higher than in city (area) in the centralized purchasing price.
Bidding period in paragraph 3 of article 10 of the present measures shall be executed.
Article 12 the bidding by tendering agency system, bidder is limited to qualified distributors in the period of validity, and implement the tender deposit as stipulated in the "bidding law" and the system of the performance bond.
Article 13 it is forbidden to public medical and health institutions to accept any form of delivery or in a disguised form on the test equipment, it is forbidden to clinical testing reagent consumables and equipment for bundles.
Public medical and health institutions of clinical laboratory USES a cooperation mode, the partners must be on the list of qualified distributors, and cooperation method agreed by taizhou health and family planning commission approval rear can implement. The clinical test reagent consumables supply price same type unit purchase price shall not be higher than the same region.
Five, unified distribution management
Article 14 the public medical and health institutions for online purchasing, can order 1-2 times a month in principle, the visual condition of the third class hospitals determine on its own.
Article 15 the winning distributors strictly enforce the provisions of the food agency to carry on the entire cold chain logistics distribution related reagents.
Article 16 strictly implement the "two votes", it is strictly prohibited to the winning distributors will be the winning distribution business subcontract, the subcontract.
Article 17 the taizhou health and family planning commission assessment method to formulate unified distribution, by city and city (area) the family planning administrative department of public health in accordance with the administrative authority of public medical and health institutions and to examine the winning distributors.
Six, bylaw
Article 18 the taizhou health and family planning commission will develop or improve specific implementation rules according to the present measures and the system.
Article 19 in clinical laboratory reagent in the process of material procurement and distribution of disciplinary violations, dealt with according to the relevant laws and regulations and discipline regulations.
Article 20 hereof by taizhou health and family planning commission is responsible for the concrete implementation and interpretation. City and each city (area), regulations are inconsistent with these measures system, since the way to release from the date of the revocation or partially abolished. |
